Inflammatory Bowel Disease Biologics Market Size to Surge to USD 130.8 Billion by 2036, India Leads at 10.1% CAGR
The inflammatory bowel disease biologics market is forecast to expand from USD 60.73 billion in 2026 to USD 130.81 billion by 2036, registering an 8.0% CAGR over the forecast period. Fact.MR attributes this expansion to the rising prevalence and diagnosis of inflammatory bowel disease, increasing adoption of biologics for moderate-to-severe cases, and the continued introduction of therapies...
0 Commentarios 0 Acciones 6 Views 0 Vista previa
AC Mingle https://acmingle.com